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Bioscience 
Newcastle disease virus (NDV) was classified into the order 
Mononegalavirales, family Paramyxoviridae, su b-famil y Paramyxovirinae and 
genus Avulavirus. The genome consists of a single stranded, non-segmented, 
enveloped negative sense RNA which consists of about 15 kb, encoding six 
viral proteins which are the phosphoprotein (P), matrix protein (M), fusion 
protein (F), hemagglutinin-neuraminidase protein (HN), polymerase (L) and 
nucleoprotein (NP). NDV causes a highly contagious, generalized virus disease 
of domestic poultry and wild birds but only mild conjunctivitis and laryngytis in 
humans. Inoculation of live NDV strain V4(UPM), a local heat resistant variant 
of the Queensland vaccine strain, V4HR, showed visible cytolytic effects on 
CEM-SS and HL-60 leukemic cells. Therefore, three approaches were taken to 
study the effect of V4 (UPM) against the two leukemic cell lines which are via 
morphological observation, cytopathic effect and biochemical study. The 
morphological changes observed via inverted light microscopy include cell 
shrinkage and blebbing of the cell membrane as well as membrane-bound 
apoptotic bodies. Results obtained from microtetrazolium cytotoxicity assay 
showed a titre of 110.6 and 150.9 HAUIml of the virus reducing the cell 
population to 50% viability for HL 60 and CEM-SS, respectively. The virus 
affects cell proliferation in a way that it reduces viability abruptly at 24 hours 
postinoculation in HL 60 cell population while in CEM-SS cell population 
proliferation was inhibited almost immediately after inoculation. Morphological 
observation using the differential uptake of acridine orange and propidium 
iodide dyes showed the cells were undergoing apoptosis. The early apoptotic 
cells which which had intact membranes but have started to fragment their 
DNA, still had green cytoplasm and nuclei but condensation of the chromatin 
were visible as bright green patches at the brim of the nucleus membrane. 
lnvagination of plasma membrane or blebbing appearance on the cell surface 
was also apparent. Late apoptosis showing bright red cells surrounded with 
apoptotic bodies were also observed in cell populations inoculated with the 
virus. The DNA of infected CEM-SS and HL 60 cells produced a DNA laddering 
profile on agarose-gel electrophoresis, a biochemical marker which is frequently 
regarded as the biochemical hallmark of apoptosis. Electron microscopy also 
confirmed the morphological structures indicating apoptosis was involved in the 
death of cells treated with the virus. In conclusion, based on the findings of 
these experiments, the mechanism by which live NDV strain V4(UPM) can 
induce cytolysis in CEM-SS and HL-60 cells is via apoptosis. Thus, it may be 
possible to further develop V4(UPM), a local oncolytic NDV vaccine strain, for 
the future choice of treatment in cancer patients. 
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Biosains 
Virus Newcastle disease atau singkatannya, NDV, telah dikTasi7dkdkan 
didalam order Mononegalavirales, famili Paramyxoviridae, sub-famili 
Paramyxovirinae and genus Avulavirus adalah sangat mudah berjangkit dan 
menyebebkan kematian serta kerugian dalam industri penternakan ayam dan 
burung di serata dunia. Genom NDV terdiri dari rantaian RNA yang bersense 
negative, tidak bersegmen serta berselaput. Genom ini mempunyai lebih 
kurang 16000 base yang mengkodkan 6 protein iaitu phosphoprotein (P), 
protein matrix (M), protein fusion (F), protein hemagglutinin-neuraminidase 
(HN), polymerase (L) dan nukleoprotein (NP). Strain V4(UPM) pada asalnya 
adalah strain vaksin Queensland V4HR yang telah diadaptasi untuk kesesuaian 
ternakan di Malaysia. Tiga pendekatan diusulkan untuk mengkaji kesan strain 
V4(UPM) iaitu melalui perubahan morfologi, kesan sitopatik dan kesan 
biokimia. Perubahan morfologi yang didatakan adalah pengecutan sel serta 
terbentuknya benjulan-benjulan di atas permukaan membran sel. Assai 
sitotoksik menggunakan garam MTT memberikan bacaan TCIDSO 110.6 
HAUIml bagi sel-sel HL 60 dan 150.9 HAUIml bagi sel-sel CEM-SS. Virus ini 
mengakibatkan pengurangan peratusan bilangan set-sel hidup dalam populasi 
sel HL 60 secara mendadak 24 jam selepas inokulasi. Manakala peratusan 
bilangan sel-sel hidup dalam populasi sel CEM-SS menurun hampir serta merta 
selepas inokulasi. Pengamatan yang lebih mendalam dari segi morfologi 
menggunakan prinsip penerapan membrane yang berbeza dua pewarna 
fluoresen akridin jingga dan propidium iodide menunjukkan sel-sel yang 
diinfeksi melalui proses apoptosis. Pengenal pastian sel-sel CEM-SS dan HL 
60 terinfeksi yang telah diwarnai mengalami apoptosis pada peringkat awalan 
ialah pewarnaan sitoplasma dan nucleus dengan warna hijau serta hijau terang 
di pergigian membran nukleus seperti bulan sabit serta terhasil benjulan pada 
perrnukaan membran sel. Apoptosis peringkat akhiran pula, menunjukkan 
sitoplasma sel berwarna merah terang serta dikelilingi badan-badan apoptosis 
yang kecil. Apabila DNA sel-sel CEM-SS dan HL 60 yang telah di inokulasikan 
dengan virus diekstrak dan dijalankan elektroforesi agar, profil seperti tetangga 
DNA yang terbelah secara spesifik terhasil, iaitu salah satu daripada ciri 
penentu apoptosis secara biokimia. Pengamatan melalui mikroskop elektron 
juga mengesahkan lagi pemerhatian bahawa sel-sel tersebut mengalami 
apoptosis. Laporan saintifik terdahulu telahpun mendatakan bahawa beberapa 
strain NDV yang lain telah mampu mengecutkan sel barah manusia yang telah 
diinfeksikan ke atas tikus (xenograf) serta menyembuhkan pesakit barah kronik. 
Maka kesimpulannya, melalui kajian-kajian yang telah dijalankan ini, NDV strain 
vaksin tempatan V4(UPM) mampu mencetus pemusnahan sel leukemia CEM- 
SS dan HL 60 secara apoptosis dan berpotensi untuk dimajukan sebagai agen 
anti-barah pilihan pada masa yang akan datang. 
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CHAPTER l 
INTRODUCTION 
Newcastle disease virus (NDV) belongs to the Avulavirus genus, 
Paramyxovirinae sub-family Paramyxoviridae family and Mononegalavirales 
order (Mayo 2002a,b; Meyyappan, 2003; Wali, 2003). NDV was formerly known 
as APMV-1 and is a veterinary virus which infects chicken among other avian 
hosts, causing economic losses (htt~://www.e~ix.hazard.net/to~ics/ 
animal/newcastl.htm). Although NDV causes a potentially fatal, respiratory 
disease (Newcastle disease) in birds, it causes only minor illness in humans. 
Several reviews have documented the mild to moderate side effects in humans 
exposed to NDV vaccines which are mild flu-like symptoms, conjunctivitis, and 
laryngitis (Alexander and Allen, 1974; Csatary et al., 1993; Kirn and 
McCormick, 1996; Nelson 1999; Sinkovics and Horvath, 2000; Omar et al., 
2002). Replication of NDV appears to be substantially better in human cancer 
cells than it does in most normal human cells (Reichard et al., 1992). In 
numereous clinical trials, NDV-based immunotherapy therapy has been 
reported to be of benefit to the patients (Mobus et al., 1993; Csatary et al., 
1993; 1999; Zorn et al., 1997; Ockert et al., 1996; Ahlert et a/., 1997; Pecora et 
a/., 2002) . 
Historically, Wheelock and Dingle were the first to report positive results using 
NDV in the treatment of an acute leukemic patient in 1964 
(http://www. nci. nih.nov/cancerinfo/ pdq/cam/NDV ). Since then many other NDV 
strains were used in clinical trials to treat various human cancers. Among the 
NDV strains used for these clinical trials were Cassel's 73-T, MTH-68, Ulster, 
Hickman and PV701 (Sinkovics and Horvath 1993; 2000; Omar et a/., 2002). 
Administration of NDV in these clinical trails were in the form of oncolysates 
(73T) which were prepared from virus-infected cancer cells comprising of cell 
membrane fragments and viral and cancer cell proteins, whole cell vaccines 
(Ulster) which was prepared using autologous tumour cells infected with virus 
and infection of the patient with the virus itself (73T, MTH-68, Hickman and 
PV701). 
The V4 strain was isolated and identified by G.Simn?ons in 1966 in 
Queensland, Australia. Being avirulent and able to induce immunogenic 
reactions, a thermostable and heat resistant vaccine strain known as V4HR 
was developed as a vaccine strain which could be administered orally by 
mixing onto chicken feed or other routes such as intranasal spray for 
commercial and village chickens (Spradbrow and Samuel, 1991). V4(UPM) is a 
heat tolerant variant of this vaccine strain and used on local chickens since 
1985 (Aini et a/. , 1986) . 
Problem Statement and Hypothesis 
NDV researchers have realized that it is crucial to determine the mode of action 
exerted by the virus as with any potential anticancer agent. Based on the 
history of the ability of a variety of international NDV strains which excelled as 
an oncolytic agent, a preliminary research was undertaken using V4(UPM) 
strain as a potential oncolytic agent in order to prove that it is able to induce 
apoptotic cell death. An in vitro study of the effects of V4(UPM) or any other 
local NDV strains on acute leukemic cell lines have never yet been done. This 
has led to the design of the experimental approach implemented in this study. 
Both cellular and molecular changes in treated cell populations will be 
examined and compared with untreated populations in a time course manner. 
Hence, either necrotic or apoptotic cell death could be suggested. 
Objectives 
The main objective of the project is to establish whether the local NDV vaccine 
strain V4(UPM) is a suitable candidate to be developed as an anticancer agent 
by inducing apoptotic cell death. This preliminary study mainly focused on the 
evaluation of the in vitro effects of the virus strain on commercially established 
leukemic cell lines CEM-SS and HL 60. Experiments designed in this study 
were mainly to determine the mode of cell death in vitro via morphological, 
ultrastructurai and biochemical studies. 
Therefore, this study was undertaken to: 
1. Assess the in vitro effects of the virus strain on commercially established 
leukemic cell lines CEM-SS and HL 60; 
2. Determine the mode of cell death induced by NDV strain V4 (UPM) in 
leukemic cell lines. 
Study Outline 
Three steps of the study were used to achieve the objectives as stated above. 
The first step was the screening and preparation of the virus of choice and cell 
lines to be used. A screening process of various types of cancereous cell lines 
was carried out to determine which cell line was to be used for this study, while 
several types of NDV strians were screened for the study. Cytotoxic assays 
using MTT was the chosen method for all screening purposes. 
It was then determined that two leukemic cell lines, HL 60, an acute 
promyelocytic leukemia cell line, and CEM-SS, a T lymphoblastic leukemia cell 
line would be used in the study. The virus strain of choice was also determined 
to be NDV strain V4 (UPM), a heat stable vaccine strain. In the subsequent 
stage, determination of the suitable dose which is the ability of the virus to 
inhibit 50% of tissue culture proliferation (TCIDS~), for the treatment of the 
cancereous cell lines was carried out. The determined dose was used 
throughout the rest of the study. 
Finally the morphology, cytopathic effects and biochemical analysis of the 
treated cell were determined. Morphological studies included observations 
through inverted light microscopy, fluorescence microscopy and scanning 
electromicroscopy (SEM). Cytopathic effects of the virus against the selected 
cell lines was done through proliferative assays and scoring of viable, apoptotic 
and necrotic cells. In the biochemical analysis the DNA content of treated and 
untreated cells were compared. 
PERPUSTAKAAN SULTAN ABDUL SAMAD 
UNIVESITI WTRA MALAYSIA 
CHAPTER ll 
LITERATURE REVIEW 
Newcastle Disease Virus 
In a review by Spradbrow, Newcastle disease (ND) was the name given by 
Doyle to a highly contagious viral infection of poultry in an outbreak on a farm 
near Newcastle upon Tyne in 1926. At about the same time, Kranveld observed 
similar symptoms in Jakarta, Indonesia (Spradbrow, 1987; Seal et al., 2000). 
The virus was classified into the order Mononegalavirales, family 
Paramyxoviridae, sub-family Paramyxovirinae. Initially, NDV was considered as 
the prototype for the genus Paramyxovirus but was placed within the genus 
Rubulavirus in 1993 (Rima et al., 1995; deLeeuw and Peeters, 1999; Seal et a/., 
2000; Yusoff and Tan, 2001). It is now placed within the genus Avulavirus by 
the International Committee on the Taxanomy of Viruses (Mayo, 2002a,b; 
Meyyappan, 2003; Wali, 2003). The virus is a membrane-enveloped virus ot 
roughly spherical spiky structure with a helical nucleocapsid surrounding the 
viral genome. The genome consists of a single stranded, non-segmented, 
negative sense RNA. The size of the genome consists of 15186 bases, 
encoding six viral proteins which are phosphoprotein (PI 53 kDa), matrix protein 
(M, 40 kDa), fusion protein (F, 67 kDa), hemagglutinin-neuraminidase protein 
(HN, 74 kDa), large protein (L, 200 kDa) and nucleocapsid protein (NP, 55 kDa) 
(Phillips et al., 1998; Yusoff and Tan, 2001; Schirrmacher, 2005). Three 
proteins make up the nucleocapsid which mainly consists of the NP followed by 
L and P. The envelope is a lipid bilayer derived from the host cell plasma 
membrane with protrusions of the HN and F proteins giving a characteristic 
